Immunological characteristics of bronchoalveolar lavage fluid and blood across connective tissue disease-associated interstitial lung diseases

被引:2
|
作者
Hirano, Aiko [1 ]
Sakashita, Aki [1 ]
Fujii, Wataru [1 ]
Bassler, Kevin [2 ]
Tsuji, Taisuke [3 ]
Kadoya, Masatoshi [4 ]
Omoto, Atsushi [4 ]
Hiraoka, Noriya [3 ]
Imabayashi, Tatsuya [5 ]
Kaneko, Yoshiko [5 ]
Sofue, Hideaki [1 ]
Maehara, Yosuke [6 ]
Seno, Takahiro [1 ]
Wada, Makoto [1 ]
Kohno, Masataka [1 ]
Fukuda, Wataru [4 ]
Yamada, Kei [6 ]
Takayama, Koichi [5 ]
Kawahito, Yutaka [1 ]
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Inflammat & Immunol, Kyoto, Japan
[2] Aimed Analyt GmbH, Bonn, Germany
[3] Japanese Red Cross Kyoto Daiichi Hosp, Dept Resp Med, Kyoto, Japan
[4] Japanese Red Cross Kyoto Daiichi Hosp, Ctr Rheumat Dis, Kyoto, Japan
[5] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pulm Med, Kyoto, Japan
[6] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Radiol, Kyoto, Japan
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
single-cell RNA sequencing; genetics; interstitial lung disease; connective tissue disease; systemic autoimmune rheumatic disease; RHEUMATOLOGY CLASSIFICATION CRITERIA; 2022; AMERICAN-COLLEGE; ENDOPLASMIC-RETICULUM STRESS; SYSTEMIC-SCLEROSIS; SJOGRENS-SYNDROME; CELLS; LEAGUE; ALLIANCE; GRANULOMATOSIS; PATHOGENESIS;
D O I
10.3389/fimmu.2024.1408880
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interstitial lung disease (ILD) is a serious complication of connective tissue diseases (CTDs). The heterogeneity of ILDs reflects differences in pathogenesis among diseases. This study aimed to clarify the characteristics of CTD-ILDs via a detailed analysis of the bronchoalveolar lavage fluid (BALF) and blood immune cells. BALF and blood samples were collected from 39 Japanese patients with newly diagnosed ILD: five patients with Sj & ouml;gren's syndrome (SS), eight patients with dermatomyositis (DM), six patients with rheumatoid arthritis (RA), six patients with systemic sclerosis, four patients with anti-neutrophil cytoplasmic antibody-associated vasculitis, and 10 patients with idiopathic interstitial pneumonia. We performed single-cell RNA sequencing to analyze the gene expression profiles in these patients' immune cells. In patients with SS, B cells in the BALF were increased and genes associated with the innate and acquired immunity were enriched in both the BALF and blood. In contrast, patients with DM showed an upregulation of genes associated with viral infection in both the BALF and blood. In patients with RA, neutrophils in the BALF tended to increase, and their gene expression patterns changed towards inflammation. These disease-specific characteristics may help us understand the pathogenesis for each disease and discover potential biomarkers.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Interstitial Lung Disease Associated with Connective Tissue Diseases
    Peredo, Ruben A.
    Mehta, Vivek
    Beegle, Scott
    LUNG INFLAMMATION IN HEALTH AND DISEASE, VOL II, 2021, 1304 : 73 - 94
  • [32] Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities?
    Sanchez Mitacc, Martin Nikolai
    Torres-Zevallos, Hernando
    Albacar, Nuria
    Francesqui, Joel
    Cuerpo, Sandra
    Lucena, Carmen
    Boada, Marc
    Espinosa, Gerard
    Castellanos, Raul
    Vinas, Odette
    Ruiz, Estibaliz
    Perez, Albert
    Agust, Carlos
    Prieto, Sergio
    Ramirez, Jose
    Sanchez, Marcelo
    Hernandez-Gonzales, Fernanda
    Sellares, Jacobo
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [33] Treatment approach to connective tissue disease-associated interstitial lung disease
    Wilson, Timothy M.
    Solomon, Joshua J.
    Demoruelle, M. Kristen
    CURRENT OPINION IN PHARMACOLOGY, 2022, 65
  • [34] Connective Tissue Disease-Associated Interstitial Lung Disease A Call for Clarification
    Fischer, Aryeh
    West, Sterling G.
    Swigris, Jeffrey J.
    Brown, Kevin K.
    du Bois, Roland M.
    CHEST, 2010, 138 (02) : 251 - 256
  • [35] Diagnosis and Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease
    Vij, Rekha
    Strek, Mary E.
    CHEST, 2013, 143 (03) : 814 - 824
  • [36] RITUXIMAB FOR THE TREATMENT OF CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Chartrand, Sandra
    Swigris, Jeffrey J.
    Peykova, Lina
    Fischer, Aryeh
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2015, 32 (04) : 296 - 304
  • [37] Updates in the management of connective tissue disease-associated interstitial lung disease
    Kavadichanda, Chengappa
    Naidu, G. S. R. S. N. K.
    INDIAN JOURNAL OF RHEUMATOLOGY, 2021, 16 (05) : 109 - 115
  • [38] A Clue to Diagnosing Connective Tissue Disease-Associated Interstitial Lung Disease
    Teramoto, Shinji
    Komiya, Kosaku
    Akashi, Shunsuke
    Kawashima, Masahiro
    CHEST, 2011, 139 (03) : 722 - 722
  • [39] Current approach to connective tissue disease-associated interstitial lung disease
    Solomon, Joshua J.
    Chartrand, Sandra
    Fischer, Aryeh
    CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (05) : 449 - 456
  • [40] Rituximab in autoimmune connective tissue disease-associated interstitial lung disease
    Sharp, Charles
    McCabe, Melanie
    Dodds, Nick
    Edey, Anthony
    Mayers, Lloyd
    Adamali, Huzaifa
    Millar, Ann B.
    Gunawardena, Harsha
    RHEUMATOLOGY, 2016, 55 (07) : 1318 - 1324